A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users
Serious adverse events: None reported in published research
Signs of infection at the injection site: Increasing redness, warmth, swelling, or discharge
Beef, chicken, tofu and shiitake mushrooms are commonly available foods high in both Zinc and Selenium
A consistent bedtime routine improves sleep quality
Stay Hydrated : Drinking plenty of water can help manage side effects like nausea